» Authors » Rinat A Maksyutov

Rinat A Maksyutov

Explore the profile of Rinat A Maksyutov including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 652
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohlopkova O, Yakovlev S, Emmanuel K, Kabanov A, Odnoshevsky D, Kartashov M, et al.
Microorganisms . 2023 Jun; 11(6). PMID: 37374935
Background: Q fever is a zoonotic infectious disease characterized by fever, malaise, chills, significant weakness, and muscle pain. In some cases, the disease can become chronic and affect the inner...
2.
Ryzhikov A, Ryzhikov E, Bogryantseva M, Usova S, Nechaeva E, Danilenko E, et al.
Vaccines (Basel) . 2023 May; 11(5). PMID: 37243102
The State Research Center of Virology and Biotechnology "VECTOR" of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is...
3.
Shishkina L, Mazurkov O, Bormotov N, Skarnovich M, Serova O, Mazurkova N, et al.
Viruses . 2023 Jan; 15(1). PMID: 36680245
Background: Since most of the modern human population has no anti-smallpox immunity, it is extremely important to develop and implement effective drugs for the treatment of smallpox and other orthopoxvirus...
4.
Mozhaitsev E, Suslov E, Rastrepaeva D, Yarovaya O, Borisevich S, Khamitov E, et al.
Viruses . 2023 Jan; 15(1). PMID: 36680072
Despite the fact that the variola virus is considered eradicated, the search for new small molecules with activity against orthopoxviruses remains an important task, especially in the context of recent...
5.
Svyatchenko V, Ternovoi V, Lutkovskiy R, Protopopova E, Gudymo A, Danilchenko N, et al.
Microorganisms . 2023 Jan; 11(1). PMID: 36677472
In this study, we investigated the features of the infectious process by simulating co-infection with SARS-CoV-2 and human adenovirus type 5 (HAdV-5) or influenza A virus (IAV) in vitro and...
6.
Kolosova N, Ilyicheva T, Unguryan V, Danilenko A, Svyatchenko S, Onhonova G, et al.
Pathogens . 2022 Nov; 11(11). PMID: 36422639
The circulation of seasonal influenza in 2020-2021 around the world was drastically reduced after the start of the COVID-19 pandemic and the implementation of mitigation strategies. The influenza virus circulation...
7.
Filimonov A, Yarovaya O, Zaykovskaya A, Rudometova N, Shcherbakov D, Chirkova V, et al.
Viruses . 2022 Oct; 14(10). PMID: 36298709
In order to test the antiviral activity, a series of usnic acid derivatives were synthesized, including new, previously undescribed compounds. The activity of the derivatives against three strains of SARS-CoV-2...
8.
Yarovaya O, Shcherbakov D, Borisevich S, Sokolova A, Gureev M, Khamitov E, et al.
Viruses . 2022 Jun; 14(6). PMID: 35746766
In the present work we studied the antiviral activity of the home library of monoterpenoid derivatives using the pseudoviral systems of our development, which have glycoproteins of the SARS-CoV-2 virus...
9.
Dolskiy A, Gudymo A, Taranov O, Grishchenko I, Shitik E, Prokopov D, et al.
Front Mol Biosci . 2022 Feb; 8:821506. PMID: 35118120
The novel coronavirus disease COVID-19 has become one of the most socially significant infections. One of the main models for COVID-19 pathogenesis study and anti-COVID-19 drug development is laboratory animals...
10.
Borisevich S, Khamitov E, Gureev M, Yarovaya O, Rudometova N, Zybkina A, et al.
Viruses . 2022 Jan; 14(1). PMID: 35062323
In this work, we evaluated the antiviral activity of Arbidol (Umifenovir) against SARS-CoV-2 using a pseudoviral system with the glycoprotein S of the SARS-CoV-2 virus on its surface. In order...